Buyout bid made for Warner Chilcott

10/26/2004 | Wall Street Journal, The

Warner Chilcott, manufacturer of estrogen-replacement therapies and acne drugs, confirmed it has been approached by one of three financial outfits with apparent plans to buy the company, but would not identify the suitor. Since three are said to be interested, the idea of an auction for the company was developing, and a source said Goldman Sachs Capital Partners is the group that made the approach.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park